These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 9796369)

  • 1. Imaging dopamine transmission in schizophrenia. A review and meta-analysis.
    Laruelle M
    Q J Nucl Med; 1998 Sep; 42(3):211-21. PubMed ID: 9796369
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Imaging synaptic neurotransmission with in vivo binding competition techniques: a critical review.
    Laruelle M
    J Cereb Blood Flow Metab; 2000 Mar; 20(3):423-51. PubMed ID: 10724107
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Baseline and amphetamine-stimulated dopamine activity are related in drug-naïve schizophrenic subjects.
    Abi-Dargham A; van de Giessen E; Slifstein M; Kegeles LS; Laruelle M
    Biol Psychiatry; 2009 Jun; 65(12):1091-3. PubMed ID: 19167701
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dopamine as the wind of the psychotic fire: new evidence from brain imaging studies.
    Laruelle M; Abi-Dargham A
    J Psychopharmacol; 1999 Dec; 13(4):358-71. PubMed ID: 10667612
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased striatal dopamine transmission in schizophrenia: confirmation in a second cohort.
    Abi-Dargham A; Gil R; Krystal J; Baldwin RM; Seibyl JP; Bowers M; van Dyck CH; Charney DS; Innis RB; Laruelle M
    Am J Psychiatry; 1998 Jun; 155(6):761-7. PubMed ID: 9619147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Abnormal striatal dopamine transmission in schizophrenia.
    Brunelin J; Fecteau S; Suaud-Chagny MF
    Curr Med Chem; 2013; 20(3):397-404. PubMed ID: 23157632
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Single photon emission computerized tomography imaging of amphetamine-induced dopamine release in drug-free schizophrenic subjects.
    Laruelle M; Abi-Dargham A; van Dyck CH; Gil R; D'Souza CD; Erdos J; McCance E; Rosenblatt W; Fingado C; Zoghbi SS; Baldwin RM; Seibyl JP; Krystal JH; Charney DS; Innis RB
    Proc Natl Acad Sci U S A; 1996 Aug; 93(17):9235-40. PubMed ID: 8799184
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The current status of PET scanning with respect to schizophrenia.
    Sedvall G
    Neuropsychopharmacology; 1992 Aug; 7(1):41-54. PubMed ID: 1388021
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Utilization of radioligands in schizophrenia research.
    Sedvall G; Farde L; Hall H; Halldin C; Karlsson P; Nordström AL; Nyberg S; Pauli S
    Clin Neurosci; 1995; 3(2):112-21. PubMed ID: 7583617
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Positron emission tomography and single photon emission CT molecular imaging in schizophrenia.
    Erritzoe D; Talbot P; Frankle WG; Abi-Dargham A
    Neuroimaging Clin N Am; 2003 Nov; 13(4):817-32. PubMed ID: 15024964
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular imaging of schizophrenia: Neurochemical findings in a heterogeneous and evolving disorder.
    Cumming P; Abi-Dargham A; Gründer G
    Behav Brain Res; 2021 Feb; 398():113004. PubMed ID: 33197459
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of dopamine for the pathophysiology of schizophrenia.
    Meisenzahl EM; Schmitt GJ; Scheuerecker J; Möller HJ
    Int Rev Psychiatry; 2007 Aug; 19(4):337-45. PubMed ID: 17671867
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurochemical brain imaging investigations of schizophrenia.
    Soares JC; Innis RB
    Biol Psychiatry; 1999 Sep; 46(5):600-15. PubMed ID: 10472414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiotracer imaging of dopaminergic transmission in neuropsychiatric disorders.
    Verhoeff NP
    Psychopharmacology (Berl); 1999 Dec; 147(3):217-49. PubMed ID: 10639681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Examining endogenous dopamine in treated schizophrenia using [¹¹C]-(+)-PHNO positron emission tomography: A pilot study.
    Caravaggio F; Borlido C; Wilson A; Graff-Guerrero A
    Clin Chim Acta; 2015 Sep; 449():60-2. PubMed ID: 25814099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical impact of cerebral dopamine-D2 receptor scintigraphy].
    Larisch R; Klimke A
    Nuklearmedizin; 1998; 37(7):245-50. PubMed ID: 9830615
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular imaging of the dopaminergic system and its association with human cognitive function.
    Cropley VL; Fujita M; Innis RB; Nathan PJ
    Biol Psychiatry; 2006 May; 59(10):898-907. PubMed ID: 16682268
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of extrastriatal dopamine D2 receptors in schizophrenia.
    Takahashi H; Higuchi M; Suhara T
    Biol Psychiatry; 2006 May; 59(10):919-28. PubMed ID: 16682269
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extrastriatal dopamine D 2/3 receptor density and distribution in drug-naive schizophrenic patients.
    Tuppurainen H; Kuikka J; Viinamäki H; Husso-Saastamoinen M; Bergström K; Tiihonen J
    Mol Psychiatry; 2003 Apr; 8(4):453-5. PubMed ID: 12740603
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A single photon emission computed tomography scan study of striatal dopamine D2 receptor binding with 123I-epidepride in patients with schizophrenia and controls.
    Tibbo P; Silverstone PH; McEwan AJ; Scott J; Joshua A; Golberg K
    J Psychiatry Neurosci; 1997 Jan; 22(1):39-45. PubMed ID: 9002391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.